Article Text
Emergency casebook
Hyperchloraemic metabolic acidosis
Abstract
Cholestyramine carries a risk of hyperchloraemic metabolic acidosis. Being cognisant of this drug-induced adverse event may reduce diagnostic delays. Emergency physicians should be alert about this condition, in particular among patients with pre-existing chronic kidney disease, or who are taking spironolactone.
Statistics from Altmetric.com
Footnotes
Competing interests: None declared.
Patient consent: Obtained.